272 related articles for article (PubMed ID: 25596540)
21. Targeting oncogenic drivers and the immune system in melanoma.
McArthur GA; Ribas A
J Clin Oncol; 2013 Feb; 31(4):499-506. PubMed ID: 23248252
[TBL] [Abstract][Full Text] [Related]
22. Emerging Strategies in Systemic Therapy for the Treatment of Melanoma.
Ascierto PA; Flaherty K; Goff S
Am Soc Clin Oncol Educ Book; 2018 May; 38():751-758. PubMed ID: 30231371
[TBL] [Abstract][Full Text] [Related]
23. State of Melanoma: An Historic Overview of a Field in Transition.
Karapetyan L; Kirkwood JM
Hematol Oncol Clin North Am; 2021 Feb; 35(1):1-27. PubMed ID: 33759768
[TBL] [Abstract][Full Text] [Related]
24. Melanoma: from darkness to promise.
Gasent Blesa JM; Grande Pulido E; Alberola Candel V; Provencio Pulla M
Am J Clin Oncol; 2011 Apr; 34(2):179-87. PubMed ID: 20498590
[TBL] [Abstract][Full Text] [Related]
25. Drug Combinations as the New Standard for Melanoma Treatment.
Polkowska M; Czepielewska E; Kozłowska-Wojciechowska M
Curr Treat Options Oncol; 2016 Dec; 17(12):61. PubMed ID: 27766547
[TBL] [Abstract][Full Text] [Related]
26. Non-BRAF-targeted therapy, immunotherapy, and combination therapy for melanoma.
Tomei S; Wang E; Delogu LG; Marincola FM; Bedognetti D
Expert Opin Biol Ther; 2014 May; 14(5):663-86. PubMed ID: 24625306
[TBL] [Abstract][Full Text] [Related]
27. Role of the MEK inhibitor trametinib in the treatment of metastatic melanoma.
King JW; Nathan PD
Future Oncol; 2014; 10(9):1559-70. PubMed ID: 25145427
[TBL] [Abstract][Full Text] [Related]
28. Prognostic factors in metastatic melanoma patients treated with biochemotherapy and maintenance immunotherapy.
Minor DR; Moore D; Kim C; Kashani-Sabet M; Venna SS; Wang W; Boasberg P; O'Day S
Oncologist; 2009 Oct; 14(10):995-1002. PubMed ID: 19776094
[TBL] [Abstract][Full Text] [Related]
29. Treatment of Melanoma CNS Metastases.
Jang S; Atkins MB
Cancer Treat Res; 2016; 167():263-79. PubMed ID: 26601867
[TBL] [Abstract][Full Text] [Related]
30. Combining immunotherapy with oncogene-targeted therapy: a new road for melanoma treatment.
Aris M; Barrio MM
Front Immunol; 2015; 6():46. PubMed ID: 25709607
[TBL] [Abstract][Full Text] [Related]
31. Advances in targeted therapy for unresectable melanoma: new drugs and combinations.
Hao M; Song F; Du X; Wang G; Yang Y; Chen K; Yang J
Cancer Lett; 2015 Apr; 359(1):1-8. PubMed ID: 25578781
[TBL] [Abstract][Full Text] [Related]
32. Immunotherapy: Anti-PD-1 therapies-a new first-line option in advanced melanoma.
Sullivan RJ; Flaherty KT
Nat Rev Clin Oncol; 2015 Nov; 12(11):625-6. PubMed ID: 26416151
[No Abstract] [Full Text] [Related]
33. The intersection of immune-directed and molecularly targeted therapy in advanced melanoma: where we have been, are, and will be.
Sullivan RJ; Lorusso PM; Flaherty KT
Clin Cancer Res; 2013 Oct; 19(19):5283-91. PubMed ID: 24089441
[TBL] [Abstract][Full Text] [Related]
34. Beyond CTLA-4: novel immunotherapy strategies for metastatic melanoma.
Matikas A; Mavroudis D
Future Oncol; 2015; 11(6):997-1009. PubMed ID: 25760979
[TBL] [Abstract][Full Text] [Related]
35. Major therapeutic developments and current challenges in advanced melanoma.
Sullivan RJ; Flaherty KT
Br J Dermatol; 2014 Jan; 170(1):36-44. PubMed ID: 24443912
[TBL] [Abstract][Full Text] [Related]
36. [Molecular-target therapy for advanced malignant melanoma].
Takahashi S
Gan To Kagaku Ryoho; 2013 Jan; 40(1):19-25. PubMed ID: 23306915
[TBL] [Abstract][Full Text] [Related]
37. Targeting BRAF in melanoma: biological and clinical challenges.
Mandalà M; Voit C
Crit Rev Oncol Hematol; 2013 Sep; 87(3):239-55. PubMed ID: 23415641
[TBL] [Abstract][Full Text] [Related]
38. Advances in the treatment of malignant melanoma.
Krementz ET; Creach O
Proc Natl Cancer Conf; 1970; 6():529-42. PubMed ID: 5458120
[No Abstract] [Full Text] [Related]
39. [Adjuvant and palliative therapy of melanoma. Current status].
Tilgen W
Chirurg; 1994 Mar; 65(3):153-63. PubMed ID: 7514966
[TBL] [Abstract][Full Text] [Related]
40. A Decade of Success in Melanoma Immunotherapy and Targeted Therapy: What Every Radiologist Should Know.
Chen M; Smith DA; Yoon JG; Vos D; Kikano EG; Tirumani SH; Ramaiya NH
J Comput Assist Tomogr; 2022 Jul-Aug 01; 46(4):621-632. PubMed ID: 35675685
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
